The health system already offered buprenorphine at its emergency departments, inpatient care settings and specialty outpatient clinics. The 18 outpatient clinics will now integrate buprenorphine treatment into primary care to further boost access to the drug.
Each clinic is staffed by a specially-trained clinician who is licensed to authorize buprenorphine prescriptions.
“NYC Health + Hospitals sees approximately 20,000 unique patients with opioid use disorder every year, many of whom aren’t ready to enter into a substance treatment program,” Mitchell Katz, MD, president and CEO of NYC Health + Hospitals, said in a press release. “Empowering primary care providers to play a greater role in connecting patients to care for opioid addiction is a useful strategy since these are the clinicians most likely to have ongoing relationships with these patients.”
More articles on opioids:
Amazon unveils cloud, voice initiatives to address opioid addiction
Rural mothers giving birth to more babies with neonatal abstinence syndrome, research finds
Washington county deploys natural disaster strategy for opioid epidemic
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
